FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054118035> ?p ?o ?g. }

• W2054118035 endingPage "132" @default.
• W2054118035 startingPage "126" @default.
• W2054118035 abstract "The objective of this study was to assess the toxicity and potential efficacy of the adjuvant administration of an iodine 125 (125I)-labeled monoclonal antibody 425 for primary glioblastoma multiforme. From January 29, 1987, to October 1, 1993, 60 patients with a diagnosis of glioblastoma multiforme received an average of three intravenous or intraarterial injections of 125I-labeled antiepidermal growth factor receptor monoclonal antibody (1251425). All patients had biopsy or resection followed by postoperative radiation therapy. Patients were included who had either stereotactic irradiation or brachytherapy (5 patients), or who were not candidates for these treatments. Stratification was made by Karnofsky performance status (KPS) and age. Treatments were administered on an outpatient basis. The mean KPS was 78, and the total cumulative dose of 125I 425 was approximately 150 mCi. Among this entire group were 6 patients who received 10–80 mg of unlabeled “blocking” 425 to block binding sites on non-tumor cells prior to the second intravenous infusion of 125I 425. No patients were excluded from the statistical analysis. The median actuarial survival for all patients treated adjuvantly for glioblastoma multiforme was 13 months. Both age and KPS correlated positively with survival, as would be expected. The toxicity from the administration of repeated doses of 125I 425 was low. No patient had chronic toxicity attributed to the monoclonal antibody therapy. Acute toxicity was observed in 1 patient who received a single dose >60 mCi. We conclude that the repeated administration of 1251425 is safe and may have some benefit in the management of primary glioblastoma multiforme. This may be especially true for patients who do not qualify for other forms of more aggressive management. A prospective randomized trial should be performed. © 1995 Wiley-Liss, Inc." @default.
• W2054118035 created "2016-06-24" @default.
• W2054118035 creator A5011894643 @default.
• W2054118035 creator A5015234400 @default.
• W2054118035 creator A5019956173 @default.
• W2054118035 creator A5022204564 @default.
• W2054118035 creator A5025801354 @default.
• W2054118035 creator A5036086237 @default.
• W2054118035 creator A5050328478 @default.
• W2054118035 creator A5053401288 @default.
• W2054118035 creator A5054998181 @default.
• W2054118035 creator A5060026719 @default.
• W2054118035 creator A5062927748 @default.
• W2054118035 creator A5073799373 @default.
• W2054118035 creator A5079259495 @default.
• W2054118035 creator A5079728565 @default.
• W2054118035 creator A5086197091 @default.
• W2054118035 creator A5089074301 @default.
• W2054118035 creator A5090807936 @default.
• W2054118035 date "1995-01-01" @default.
• W2054118035 modified "2023-09-24" @default.
• W2054118035 title "Utilization of125I monoclonal antibody in the management of primary glioblastoma multiforme" @default.
• W2054118035 cites W1982704632 @default.
• W2054118035 cites W1988159991 @default.
• W2054118035 cites W2026918336 @default.
• W2054118035 cites W2056242216 @default.
• W2054118035 cites W2058426435 @default.
• W2054118035 cites W2061210157 @default.
• W2054118035 cites W2062465907 @default.
• W2054118035 cites W2071331821 @default.
• W2054118035 cites W2080580789 @default.
• W2054118035 cites W2088925558 @default.
• W2054118035 cites W2093014822 @default.
• W2054118035 cites W2098058543 @default.
• W2054118035 cites W2139021843 @default.
• W2054118035 cites W2146492456 @default.
• W2054118035 cites W2313078094 @default.
• W2054118035 cites W2316765704 @default.
• W2054118035 doi "https://doi.org/10.1002/roi.2970030305" @default.
• W2054118035 hasPublicationYear "1995" @default.
• W2054118035 type Work @default.
• W2054118035 sameAs 2054118035 @default.
• W2054118035 citedByCount "11" @default.
• W2054118035 countsByYear W20541180352012 @default.
• W2054118035 countsByYear W20541180352016 @default.
• W2054118035 crossrefType "journal-article" @default.
• W2054118035 hasAuthorship W2054118035A5011894643 @default.
• W2054118035 hasAuthorship W2054118035A5015234400 @default.
• W2054118035 hasAuthorship W2054118035A5019956173 @default.
• W2054118035 hasAuthorship W2054118035A5022204564 @default.
• W2054118035 hasAuthorship W2054118035A5025801354 @default.
• W2054118035 hasAuthorship W2054118035A5036086237 @default.
• W2054118035 hasAuthorship W2054118035A5050328478 @default.
• W2054118035 hasAuthorship W2054118035A5053401288 @default.
• W2054118035 hasAuthorship W2054118035A5054998181 @default.
• W2054118035 hasAuthorship W2054118035A5060026719 @default.
• W2054118035 hasAuthorship W2054118035A5062927748 @default.
• W2054118035 hasAuthorship W2054118035A5073799373 @default.
• W2054118035 hasAuthorship W2054118035A5079259495 @default.
• W2054118035 hasAuthorship W2054118035A5079728565 @default.
• W2054118035 hasAuthorship W2054118035A5086197091 @default.
• W2054118035 hasAuthorship W2054118035A5089074301 @default.
• W2054118035 hasAuthorship W2054118035A5090807936 @default.
• W2054118035 hasConcept C126322002 @default.
• W2054118035 hasConcept C126894567 @default.
• W2054118035 hasConcept C141071460 @default.
• W2054118035 hasConcept C159654299 @default.
• W2054118035 hasConcept C203014093 @default.
• W2054118035 hasConcept C2776194525 @default.
• W2054118035 hasConcept C2776694085 @default.
• W2054118035 hasConcept C2777863537 @default.
• W2054118035 hasConcept C2778227246 @default.
• W2054118035 hasConcept C29730261 @default.
• W2054118035 hasConcept C502942594 @default.
• W2054118035 hasConcept C509974204 @default.
• W2054118035 hasConcept C542903549 @default.
• W2054118035 hasConcept C71924100 @default.
• W2054118035 hasConcept C90924648 @default.
• W2054118035 hasConceptScore W2054118035C126322002 @default.
• W2054118035 hasConceptScore W2054118035C126894567 @default.
• W2054118035 hasConceptScore W2054118035C141071460 @default.
• W2054118035 hasConceptScore W2054118035C159654299 @default.
• W2054118035 hasConceptScore W2054118035C203014093 @default.
• W2054118035 hasConceptScore W2054118035C2776194525 @default.
• W2054118035 hasConceptScore W2054118035C2776694085 @default.
• W2054118035 hasConceptScore W2054118035C2777863537 @default.
• W2054118035 hasConceptScore W2054118035C2778227246 @default.
• W2054118035 hasConceptScore W2054118035C29730261 @default.
• W2054118035 hasConceptScore W2054118035C502942594 @default.
• W2054118035 hasConceptScore W2054118035C509974204 @default.
• W2054118035 hasConceptScore W2054118035C542903549 @default.
• W2054118035 hasConceptScore W2054118035C71924100 @default.
• W2054118035 hasConceptScore W2054118035C90924648 @default.
• W2054118035 hasIssue "3" @default.
• W2054118035 hasLocation W20541180351 @default.
• W2054118035 hasOpenAccess W2054118035 @default.
• W2054118035 hasPrimaryLocation W20541180351 @default.
• W2054118035 hasRelatedWork W1480650142 @default.

• next